Biolinerx Ltd ADR (BLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 427 | 304 | 255 | 11,749 | 4,943 |
| Cost of Goods | 84 | 72 | 34 | 6,089 | 822 |
| Gross Profit | 343 | 232 | 221 | 5,660 | 4,121 |
| Operating Expenses | 2,634 | 2,607 | 2,646 | 10,175 | 10,330 |
| Operating Income | -2,207 | -2,303 | -2,391 | -4,426 | -5,387 |
| Interest Expense | 304 | 276 | 420 | 4,480 | 1,625 |
| Other Income | 1,534 | -1,361 | 7,938 | 5,719 | 1,190 |
| Pre-tax Income | -977 | -3,940 | 5,127 | -3,187 | -5,822 |
| Net Income Continuous | -977 | -3,940 | 5,127 | -3,187 | -5,822 |
| Net Income | $-977 | $-3,940 | $5,127 | $-3,187 | $-5,822 |
| EPS Basic Continuous Ops | -0.22 | -1.00 | 1.39 | -1.56 | -2.91 |
| EPS Diluted Continuous Ops | -0.22 | -1.00 | 1.39 | -1.56 | -2.91 |
| EPS Diluted Before Non-Recurring Items | -0.22 | -1.00 | 1.39 | N/A | -2.80 |
| EBITDA(a) | $-2,088 | $-2,127 | $-2,226 | $-2,574 | $-4,547 |